Literature DB >> 18510956

Transseptal left heart catheterization a 50-year odyssey.

John Ross1.   

Abstract

Development in the 1950s of the transseptal technique for left heart catheterization is described. Initial studies in animals and human cadavers were followed up by left atrial puncture with measurements of left atrial and left ventricular (LV) pressure (the latter using a small plastic catheter) in patients with cardiac disease. Many such procedures were performed safely without complications. Subsequent modification of the original technique for percutaneous catheter insertion allowed placement of a larger taper-tipped catheter in the LV chamber for selective LV angiography. Early clinical research studies at the National Heart Institute were performed using the transseptal method; these included investigation of the effects of increasing afterload on the normal and failing left ventricle by means of a graded angiotensin infusion to induce a progressive increase in aortic pressure. A marked decrease in the stroke volume occurred with increased afterload in the failing heart. This finding later led to the concept of afterload mismatch with limited pre-load reserve. Another early transseptal catheterization study in which measurements of LV pressure were made at different locations within the left ventricle as well as in the left atrium confirmed the presence of cavity obliteration in some patients and true obstruction in the LV outflow tract in many others. In addition, left ventriculography showed that obstruction was caused by abnormal anterior position during systole of the anterior mitral valve leaflet. With growing acceptance of retrograde catheterization of the left ventricle, the use of the transseptal technique for diagnostic purposes declined. However, in recent years, substantial renewed application of the transseptal method has occurred for special diagnostic and therapeutic purposes, including balloon valvuloplasties and electrophysiologic ablation procedures within the left heart.

Entities:  

Mesh:

Year:  2008        PMID: 18510956     DOI: 10.1016/j.jacc.2007.12.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Transseptal access in pediatric and congenital electrophysiology procedures: defining risk.

Authors:  Johannes C von Alvensleben; Macdonald Dick; David J Bradley; Martin J LaPage
Journal:  J Interv Card Electrophysiol       Date:  2014-11-22       Impact factor: 1.900

Review 2.  Fluid dynamic aspects of ejection in hypertrophic cardiomyopathy.

Authors:  Ares Pasipoularides
Journal:  Hellenic J Cardiol       Date:  2011 Sep-Oct

3.  Particle formation and risk of embolization during transseptal catheterization: comparison of standard transseptal needles and a new radiofrequency transseptal needle.

Authors:  Gregory K Feld; Jay Tiongson; Ganiyu Oshodi
Journal:  J Interv Card Electrophysiol       Date:  2011-01-20       Impact factor: 1.900

4.  Transseptal puncture by CTP-2 method: Results from cardiac computed tomography analysis and clinical application.

Authors:  Yan Wang; Guangzhi Chen; Yang Bai; Sheng Li; Andrea Natale; Jianzeng Dong; Hong Wang; Caihua Sang; Ronghui Yu; Deyong Long; Ribo Tang; Xingpeng Liu; Xiaopeng Zhao; Yuanwen Jiang; Changsheng Ma; Dao Wen Wang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

5.  Safety of Transseptal Puncture for Access to the Left Atrium in Infants and Children.

Authors:  Matthias J Müller; David Backhoff; Heike E Schneider; Jana K Dieks; Julia Rieger; Ulrich Krause; Thomas Paul
Journal:  Pediatr Cardiol       Date:  2021-01-16       Impact factor: 1.655

Review 6.  Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature.

Authors:  Antonis S Manolis
Journal:  Curr Cardiol Rev       Date:  2017

7.  Through-needle all-optical ultrasound imaging in vivo: a preclinical swine study.

Authors:  Malcolm C Finlay; Charles A Mosse; Richard J Colchester; Sacha Noimark; Edward Z Zhang; Sebastien Ourselin; Paul C Beard; Richard J Schilling; Ivan P Parkin; Ioannis Papakonstantinou; Adrien E Desjardins
Journal:  Light Sci Appl       Date:  2017-12-01       Impact factor: 17.782

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.